Cravath represented the underwriters in the offering. BioAtla, Inc. completed its $217 million initial public offering of common stock. The transaction closed on December 18, 2020….
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
